Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
β-glucan in localized aggressive periodontitis
NCT02402296Phase 4
Key facts
- Status
- Completed
- Start
- Jan 2013
- Primary completion
- Jun 2014
- Sponsor
- Al-Azhar University
- Modality
- Polysaccharide, Dietary Supplement
- Drugs
- beta-1,3/1,6-d-glucan
- Conditions
- aggressive periodontitis
01
Overview
Phase 4, randomised, double-blind trial of beta-1,3/1,6-d-glucan in aggressive periodontitis, sponsored by Al-Azhar University. Primary endpoint: Clinical Attachment Level at Day 91. Started Jan 2013; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Patients with localized aggressive periodontitis, systemically healthy, with specific clinical attachment loss and bone destruction criteria, excluding smokers and those with recent antibiotic use.
04
Endpoints
Primary
Clinical Attachment Level
Secondary
Pocket Depth
Beyond the preview
Go deeper on NCT02402296.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02402296.